Evidence map›Paper›PMID 29213754›Full record

ReviewDementia & neuropsychologia

Treatment of vascular dementia. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology.

Sonia Maria Dozzi Brucki, Ana Cláudia Ferraz, Gabriel R de Freitas, Ayrton Roberto Massaro, Márcia Radanovic, Rodrigo Rizek Schultz, Working Group on Alzheimer's Disease and Vascular Dementia of the Brazilian Academy of Neurology

Open access · diamondAbstract readReview
In one paragraph

Review in Dementia & neuropsychologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Methanol extract ofFrontiers in pharmacology · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sonia Maria Dozzi BruckiNeurology Service, Hospital Santa Marcelina, Cognitive and Behavioral Neurology Group of Clínicas Hospital of the University of São Paulo School of Medicine (FMUSP), Referral Center for Cognitive Disorders (CEREDIC) of the FMUSP, São Paulo SP, Brazil.
Ana Cláudia FerrazD'Or Institute of Research and Teaching, University Federal Fluminense, Rio de Janeiro RJ, Brazil.
Gabriel R de FreitasInstitute of Rehabilitation Lucy Montoro.
Ayrton Roberto MassaroMedical Investigation Laboratory 27 (LIM 27), Institute of Psychiatry, School of Medicine, University of Sao Paulo, São Paulo SP, Brazil.
Márcia RadanovicSector of Behavioral Neurology of the Department of Neurology and Neurosurgery of the Federal University of São Paulo (UNIFESP), Center for Brain Aging (NUDEC) - Institute of Memory (UNIFESP), São Paulo SP, Brazil.
Rodrigo Rizek SchultzSector of Behavioral Neurology of the Department of Neurology and Neurosurgery of the Federal University of São Paulo (UNIFESP), Center for Brain Aging (NUDEC) - Institute of Memory (UNIFESP), São Paulo SP, Brazil.
Working Group on Alzheimer's Disease and Vascular Dementia of the Brazilian Academy of Neurology
Universidade de São Paulo · BRUniversidade Federal de São Paulo · BRD’Or Institute for Research and Education · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scientific Department of Cognitive Neurology and Aging of ABN had a consensus meeting to write recommendations on treatment of vascular dementia, there was no previous issue. This disease has numerous particularities and can be considered a preventable dementia. Prevention treatment is primary care of vascular risk factors or a secondary prevention of factors that could cause recurrence of ischemic or hemorrhagic brain modifications. In these guidelines we suggested only symptomatic treatment, pharmacologic or non-pharmacologic. We have reviewed current publications on MEDLINE (PubMed), LILACS e Cochrane Library databases. Recommendations are concern to the following factors and their prevention evidences, association, or treatment of vascular dementia: physical activity, tobacco use, diet and food supplements, arterial hypertension, diabetes mellitus, obesity, statins, cardiac failure, atrial fibrillation, antithrombotics, sleep apnea, carotid revascularization, symptomatic pharmacological treatment.

Indexed as

cholinesterasepharmacological treatmentpreventionvascular dementia

Identifiers

PMID29213754
PMCPMC5619040
OpenAlexW2123001852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.